Nishikawa H, Taniguchi T, Ninomiya H, Fujiwara M
Department of Pharmacology, Faculty of Medicine, Kyoto University, Japan.
Eur J Pharmacol. 1988 Jan 27;146(1):97-103. doi: 10.1016/0014-2999(88)90490-6.
The nicotinic acetylcholine receptors in the rat stomach were characterized by means of a radioligand binding assay with (-)-[3H]nicotine as ligand. Saturation binding studies on the gastric fundus membranes revealed the presence of two binding sites with dissociation constant (KD) values of 3.1 and 289 nM, and maximum binding capacity (Bmax) values of 3.6 and 76 fmol/mg protein, respectively. The Bmax of the high affinity binding site was greatest in the cardia, followed by fundal mucosa, fundal muscle, and, finally antrum. The IC50 values of cholinergic drugs to inhibit (-)-[3H]nicotine binding in fundus membranes were as follows: (-)nicotine, 0.12 nM; cytosine, 9.3 nM; acetylcholine, 17.7 nM; carbachol, 700 nM; hexamethonium, 2270 nM. The IC50 values of alpha-bungarotoxin, d-tubocurarine and atropine were greater than 100 microM. The muscarinic acetylcholine receptors were also characterized with [3H]quinuclidinyl benzilate and the choline acetyltransferase activity was measured. These results suggest that nicotinic acetylcholine receptors as well as muscarinic acetylcholine receptors are present in the rat stomach and that the regional distribution of these receptors is uneven.
以(-)-[³H]尼古丁为配体,通过放射性配体结合试验对大鼠胃中的烟碱型乙酰胆碱受体进行了表征。对胃底膜的饱和结合研究显示存在两个结合位点,解离常数(KD)值分别为3.1和289 nM,最大结合容量(Bmax)值分别为3.6和76 fmol/mg蛋白质。高亲和力结合位点的Bmax在贲门处最大,其次是胃底黏膜、胃底肌肉,最后是胃窦。胆碱能药物抑制胃底膜中(-)-[³H]尼古丁结合的IC50值如下:(-)尼古丁,0.12 nM;胞嘧啶,9.3 nM;乙酰胆碱,17.7 nM;卡巴胆碱,700 nM;六甲铵,2270 nM。α-银环蛇毒素、d-筒箭毒碱和阿托品的IC50值大于100 μM。还用[³H]喹核醇基苯甲酸酯对毒蕈碱型乙酰胆碱受体进行了表征,并测定了胆碱乙酰转移酶活性。这些结果表明,大鼠胃中存在烟碱型乙酰胆碱受体以及毒蕈碱型乙酰胆碱受体,且这些受体的区域分布不均匀。